ID   BUP1_HUMAN              Reviewed;         384 AA.
AC   Q9UBR1; A3KMF8; Q9UIR3;
DT   26-SEP-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   15-MAR-2017, entry version 138.
DE   RecName: Full=Beta-ureidopropionase;
DE            EC=3.5.1.6;
DE   AltName: Full=BUP-1;
DE   AltName: Full=Beta-alanine synthase;
DE   AltName: Full=N-carbamoyl-beta-alanine amidohydrolase;
GN   Name=UPB1; Synonyms=BUP1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RX   PubMed=10542323; DOI=10.1016/S0167-4781(99)00182-7;
RA   Vreken P., van Kuilenburg A.B.P., Hamajima N., Meinsma R.,
RA   van Lenthe H., Goehlich-Ratmann G., Assmann B.E., Wevers R.A.,
RA   van Gennip A.H.;
RT   "cDNA cloning, genomic structure and chromosomal localization of the
RT   human BUP-1 gene encoding beta-ureidopropionase.";
RL   Biochim. Biophys. Acta 1447:251-257(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND CHARACTERIZATION.
RC   TISSUE=Liver;
RX   PubMed=11508704;
RA   Sakamoto T., Sakata S.F., Matsuda K., Horikawa Y., Tamaki N.;
RT   "Expression and properties of human liver beta-ureidopropionase.";
RL   J. Nutr. Sci. Vitaminol. 47:132-138(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84;
RA   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A.,
RA   Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J.,
RA   Beare D.M., Dunham I.;
RT   "A genome annotation-driven approach to cloning the human ORFeome.";
RL   Genome Biol. 5:R84.1-R84.11(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [7]
RP   VARIANT UPB1D GLU-85, AND CHARACTERIZATION OF VARIANT UPB1D GLU-85.
RX   PubMed=15385443; DOI=10.1093/hmg/ddh303;
RA   van Kuilenburg A.B.P., Meinsma R., Beke E., Assmann B., Ribes A.,
RA   Lorente I., Busch R., Mayatepek E., Abeling N.G.G.M., van Cruchten A.,
RA   Stroomer A.E.M., van Lenthe H., Zoetekouw L., Kulik W., Hoffmann G.F.,
RA   Voit T., Wevers R.A., Rutsch F., van Gennip A.H.;
RT   "Beta-ureidopropionase deficiency: an inborn error of pyrimidine
RT   degradation associated with neurological abnormalities.";
RL   Hum. Mol. Genet. 13:2793-2801(2004).
CC   -!- FUNCTION: Converts N-carbamoyl-beta-aminoisobutyrate and N-
CC       carbamoyl-beta-alanine (3-ureidopropanoate) to, respectively,
CC       beta-aminoisobutyrate and beta-alanine, ammonia and carbon
CC       dioxide.
CC   -!- CATALYTIC ACTIVITY: 3-ureidopropanoate + H(2)O = beta-alanine +
CC       CO(2) + NH(3).
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000250|UniProtKB:Q03248};
CC       Note=Binds 1 zinc ion per subunit. {ECO:0000250|UniProtKB:Q03248};
CC   -!- ENZYME REGULATION: Allosteric enzyme with positive cooperativity
CC       toward the substrate N-carbamoyl-beta-alanine. {ECO:0000250}.
CC   -!- PATHWAY: Amino-acid biosynthesis; beta-alanine biosynthesis.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- DISEASE: Beta-ureidopropionase deficiency (UPB1D) [MIM:613161]: An
CC       inborn error of metabolism due to a defect in pyrimidine
CC       degradation. It is characterized by muscular hypotonia, dystonic
CC       movements, scoliosis, microcephaly and severe developmental delay.
CC       Patients show strongly elevated levels of N-carbamyl-beta-alanine
CC       and N-carbamyl-beta-aminoisobutyric acid in plasma, cerebrospinal
CC       fluid and urine. {ECO:0000269|PubMed:15385443}. Note=The disease
CC       is caused by mutations affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the carbon-nitrogen hydrolase superfamily.
CC       BUP family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF163312; AAF06735.1; -; mRNA.
DR   EMBL; AF169559; AAF06739.1; -; Genomic_DNA.
DR   EMBL; AF169550; AAF06739.1; JOINED; Genomic_DNA.
DR   EMBL; AF169551; AAF06739.1; JOINED; Genomic_DNA.
DR   EMBL; AF169552; AAF06739.1; JOINED; Genomic_DNA.
DR   EMBL; AF169553; AAF06739.1; JOINED; Genomic_DNA.
DR   EMBL; AF169554; AAF06739.1; JOINED; Genomic_DNA.
DR   EMBL; AF169555; AAF06739.1; JOINED; Genomic_DNA.
DR   EMBL; AF169556; AAF06739.1; JOINED; Genomic_DNA.
DR   EMBL; AF169557; AAF06739.1; JOINED; Genomic_DNA.
DR   EMBL; AF169558; AAF06739.1; JOINED; Genomic_DNA.
DR   EMBL; AB013885; BAA88634.1; -; mRNA.
DR   EMBL; CR456375; CAG30261.1; -; mRNA.
DR   EMBL; CH471095; EAW59663.1; -; Genomic_DNA.
DR   EMBL; BC131703; AAI31704.1; -; mRNA.
DR   CCDS; CCDS13827.1; -.
DR   RefSeq; NP_057411.1; NM_016327.2.
DR   UniGene; Hs.731656; -.
DR   ProteinModelPortal; Q9UBR1; -.
DR   SMR; Q9UBR1; -.
DR   BioGrid; 119703; 1.
DR   MINT; MINT-5005710; -.
DR   STRING; 9606.ENSP00000324343; -.
DR   ChEMBL; CHEMBL3430874; -.
DR   iPTMnet; Q9UBR1; -.
DR   PhosphoSitePlus; Q9UBR1; -.
DR   BioMuta; UPB1; -.
DR   DMDM; 17373540; -.
DR   MaxQB; Q9UBR1; -.
DR   PaxDb; Q9UBR1; -.
DR   PeptideAtlas; Q9UBR1; -.
DR   PRIDE; Q9UBR1; -.
DR   DNASU; 51733; -.
DR   Ensembl; ENST00000326010; ENSP00000324343; ENSG00000100024.
DR   GeneID; 51733; -.
DR   KEGG; hsa:51733; -.
DR   UCSC; uc003aaf.4; human.
DR   CTD; 51733; -.
DR   DisGeNET; 51733; -.
DR   GeneCards; UPB1; -.
DR   HGNC; HGNC:16297; UPB1.
DR   HPA; HPA000728; -.
DR   MalaCards; UPB1; -.
DR   MIM; 606673; gene.
DR   MIM; 613161; phenotype.
DR   neXtProt; NX_Q9UBR1; -.
DR   OpenTargets; ENSG00000100024; -.
DR   Orphanet; 65287; Beta-ureidopropionase deficiency.
DR   PharmGKB; PA418; -.
DR   eggNOG; KOG0808; Eukaryota.
DR   eggNOG; COG0388; LUCA.
DR   GeneTree; ENSGT00390000004906; -.
DR   HOVERGEN; HBG018848; -.
DR   InParanoid; Q9UBR1; -.
DR   KO; K01431; -.
DR   OMA; RILYGVE; -.
DR   OrthoDB; EOG091G087Q; -.
DR   PhylomeDB; Q9UBR1; -.
DR   TreeFam; TF313402; -.
DR   BioCyc; MetaCyc:HS01953-MONOMER; -.
DR   BRENDA; 3.5.1.6; 2681.
DR   Reactome; R-HSA-73621; Pyrimidine catabolism.
DR   UniPathway; UPA00131; -.
DR   GeneWiki; UPB1; -.
DR   GenomeRNAi; 51733; -.
DR   PRO; PR:Q9UBR1; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   Bgee; ENSG00000100024; -.
DR   CleanEx; HS_UPB1; -.
DR   ExpressionAtlas; Q9UBR1; baseline and differential.
DR   Genevisible; Q9UBR1; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0003837; F:beta-ureidopropionase activity; EXP:Reactome.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0019483; P:beta-alanine biosynthetic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0046135; P:pyrimidine nucleoside catabolic process; TAS:Reactome.
DR   Gene3D; 3.60.110.10; -; 1.
DR   InterPro; IPR003010; C-N_Hydrolase.
DR   Pfam; PF00795; CN_hydrolase; 1.
DR   SUPFAM; SSF56317; SSF56317; 1.
DR   PROSITE; PS50263; CN_HYDROLASE; 1.
PE   1: Evidence at protein level;
KW   Allosteric enzyme; Complete proteome; Cytoplasm; Disease mutation;
KW   Hydrolase; Metal-binding; Phosphoprotein; Polymorphism;
KW   Reference proteome; Zinc.
FT   CHAIN         1    384       Beta-ureidopropionase.
FT                                /FTId=PRO_0000204051.
FT   DOMAIN       72    366       CN hydrolase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00054}.
FT   ACT_SITE    119    119       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00054}.
FT   ACT_SITE    196    196       Proton donor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00054}.
FT   ACT_SITE    233    233       Nucleophile. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00054}.
FT   METAL        97     97       Zinc. {ECO:0000255}.
FT   METAL       158    158       Zinc. {ECO:0000255}.
FT   METAL       280    280       Zinc. {ECO:0000255}.
FT   METAL       293    293       Zinc. {ECO:0000255}.
FT   METAL       307    307       Zinc. {ECO:0000255}.
FT   MOD_RES     378    378       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q03248}.
FT   VARIANT      85     85       A -> E (in UPB1D; complete loss of
FT                                activity; dbSNP:rs34035085).
FT                                {ECO:0000269|PubMed:15385443}.
FT                                /FTId=VAR_026752.
FT   VARIANT     340    340       A -> D (in dbSNP:rs34110964).
FT                                /FTId=VAR_050280.
FT   CONFLICT    263    263       L -> LRSL (in Ref. 1; AAF06739).
FT                                {ECO:0000305}.
SQ   SEQUENCE   384 AA;  43166 MW;  62B81982D2D63CC3 CRC64;
     MAGAEWKSLE ECLEKHLPLP DLQEVKRVLY GKELRKLDLP REAFEAASRE DFELQGYAFE
     AAEEQLRRPR IVHVGLVQNR IPLPANAPVA EQVSALHRRI KAIVEVAAMC GVNIICFQEA
     WTMPFAFCTR EKLPWTEFAE SAEDGPTTRF CQKLAKNHDM VVVSPILERD SEHGDVLWNT
     AVVISNSGAV LGKTRKNHIP RVGDFNESTY YMEGNLGHPV FQTQFGRIAV NICYGRHHPL
     NWLMYSINGA EIIFNPSATI GALSESLWPI EARNAAIANH CFTCAINRVG TEHFPNEFTS
     GDGKKAHQDF GYFYGSSYVA APDSSRTPGL SRSRDGLLVA KLDLNLCQQV NDVWNFKMTG
     RYEMYARELA EAVKSNYSPT IVKE
//
